HEADER LYASE/LYASE INHIBITOR 20-MAY-10 3N3J TITLE CRYSTAL STRUCTURE OF HUMAN CARBONIC ANHYDRASE II IN COMPLEX WITH A TITLE 2 BENZENESULFONAMIDE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: CARBONIC ANHYDRASE 2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: HUMAN CARBONIC ANHYDRASE II; COMPND 5 SYNONYM: CARBONIC ANHYDRASE II, CA-II, CARBONATE DEHYDRATASE II, COMPND 6 CARBONIC ANHYDRASE C, CAC; COMPND 7 EC: 4.2.1.1; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_TAXID: 9606; SOURCE 4 GENE: HCA2; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)PLYSS; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID KEYWDS LYASE, METALLOENZYME, ZINC LIGANDS, BENZENESULFONAMIDE, INHIBITOR, KEYWDS 2 GLYCEROL, LYASE-LYASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR B.S.AVVARU,J.WAGNER,A.H.ROBBINS,R.MCKENNA REVDAT 2 08-NOV-17 3N3J 1 REMARK REVDAT 1 09-MAR-11 3N3J 0 JRNL AUTH F.PACCHIANO,M.AGGARWAL,B.S.AVVARU,A.H.ROBBINS,A.SCOZZAFAVA, JRNL AUTH 2 R.MCKENNA,C.T.SUPURAN JRNL TITL SELECTIVE HYDROPHOBIC POCKET BINDING OBSERVED WITHIN THE JRNL TITL 2 CARBONIC ANHYDRASE II ACTIVE SITE ACCOMMODATE DIFFERENT JRNL TITL 3 4-SUBSTITUTED-UREIDO-BENZENESULFONAMIDES AND CORRELATE TO JRNL TITL 4 INHIBITOR POTENCY. JRNL REF CHEM.COMMUN.(CAMB.) V. 46 8371 2010 JRNL REFN ISSN 1359-7345 JRNL PMID 20922253 JRNL DOI 10.1039/C0CC02707C REMARK 2 REMARK 2 RESOLUTION. 1.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX DEV_403 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.86 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 93.2 REMARK 3 NUMBER OF REFLECTIONS : 36202 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.154 REMARK 3 R VALUE (WORKING SET) : 0.153 REMARK 3 FREE R VALUE : 0.174 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1809 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 19.8580 - 3.5210 0.67 1975 103 0.1520 0.1640 REMARK 3 2 3.5210 - 2.7970 0.91 2623 136 0.1390 0.1660 REMARK 3 3 2.7970 - 2.4450 0.94 2682 136 0.1370 0.1660 REMARK 3 4 2.4450 - 2.2210 0.89 2532 136 0.1410 0.1540 REMARK 3 5 2.2210 - 2.0620 0.96 2696 143 0.1430 0.1470 REMARK 3 6 2.0620 - 1.9410 0.97 2755 138 0.1460 0.1660 REMARK 3 7 1.9410 - 1.8440 0.96 2698 151 0.1490 0.1690 REMARK 3 8 1.8440 - 1.7630 0.98 2783 150 0.1490 0.1630 REMARK 3 9 1.7630 - 1.6960 0.98 2752 144 0.1680 0.2010 REMARK 3 10 1.6960 - 1.6370 0.97 2753 150 0.1820 0.2320 REMARK 3 11 1.6370 - 1.5860 0.98 2769 139 0.2040 0.2470 REMARK 3 12 1.5860 - 1.5410 0.96 2710 137 0.2220 0.2310 REMARK 3 13 1.5410 - 1.5000 0.95 2665 146 0.2770 0.2870 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 0.30 REMARK 3 SHRINKAGE RADIUS : 0.05 REMARK 3 K_SOL : 0.50 REMARK 3 B_SOL : 60.75 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.190 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 25.60 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 20.51 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.91900 REMARK 3 B22 (A**2) : -1.07400 REMARK 3 B33 (A**2) : 1.99200 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 1.68200 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 2188 REMARK 3 ANGLE : 1.282 2978 REMARK 3 CHIRALITY : 0.077 307 REMARK 3 PLANARITY : 0.007 384 REMARK 3 DIHEDRAL : 14.202 818 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN A OR ELEMENT ZN AND NOT ELEMENT H REMARK 3 ORIGIN FOR THE GROUP (A): -9.5894 -1.7516 15.7559 REMARK 3 T TENSOR REMARK 3 T11: 0.0946 T22: 0.0931 REMARK 3 T33: 0.0918 T12: 0.0001 REMARK 3 T13: -0.0010 T23: 0.0032 REMARK 3 L TENSOR REMARK 3 L11: 0.4544 L22: 0.3847 REMARK 3 L33: 0.4650 L12: -0.0773 REMARK 3 L13: -0.0649 L23: -0.0306 REMARK 3 S TENSOR REMARK 3 S11: -0.0103 S12: -0.0208 S13: 0.0027 REMARK 3 S21: -0.0288 S22: 0.0190 S23: -0.0080 REMARK 3 S31: -0.0016 S32: 0.0119 S33: -0.0073 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: CHAIN I AND NOT ELEMENT H REMARK 3 ORIGIN FOR THE GROUP (A): -3.7900 5.2685 14.2021 REMARK 3 T TENSOR REMARK 3 T11: 0.1436 T22: 0.1144 REMARK 3 T33: 0.1312 T12: 0.0050 REMARK 3 T13: 0.0217 T23: 0.0286 REMARK 3 L TENSOR REMARK 3 L11: 0.1168 L22: 0.5742 REMARK 3 L33: 0.1291 L12: 0.2522 REMARK 3 L13: -0.1228 L23: -0.2641 REMARK 3 S TENSOR REMARK 3 S11: -0.0022 S12: 0.0116 S13: 0.0253 REMARK 3 S21: -0.0136 S22: -0.0150 S23: -0.0101 REMARK 3 S31: -0.0241 S32: 0.0065 S33: -0.0010 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3N3J COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 26-MAY-10. REMARK 100 THE DEPOSITION ID IS D_1000059334. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-APR-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RUH3R REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : RIGAKU VARIMAX REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO, HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK, HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 36469 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.500 REMARK 200 RESOLUTION RANGE LOW (A) : 19.900 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.8 REMARK 200 DATA REDUNDANCY : 2.300 REMARK 200 R MERGE (I) : 0.09000 REMARK 200 R SYM (I) : 0.09000 REMARK 200 FOR THE DATA SET : 40.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.55 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.3 REMARK 200 DATA REDUNDANCY IN SHELL : 2.10 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.17700 REMARK 200 FOR SHELL : 3.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX 1.6.1_403 REMARK 200 STARTING MODEL: PDB ENTRY 2ILI REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.95 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.08 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.05 M TRIS-HCL, 1.3 M SODIUM CITRATE, REMARK 280 5 UL + 5 UL DROPLET, PH 7.8, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 20.71650 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY IS A MONOMER REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 27 56.41 -142.23 REMARK 500 LYS A 76 -81.84 -119.33 REMARK 500 LYS A 111 -1.09 74.74 REMARK 500 PHE A 176 75.50 -154.62 REMARK 500 ASN A 244 47.15 -91.47 REMARK 500 LYS A 252 -136.95 55.92 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 262 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 WWV A 263 N1 REMARK 620 2 HIS A 96 NE2 115.5 REMARK 620 3 HIS A 94 NE2 110.6 104.8 REMARK 620 4 HIS A 119 ND1 115.6 97.8 111.5 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 262 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE WWV A 263 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3N2P RELATED DB: PDB REMARK 900 THE SAME PROTEIN WITH A SIMILAR INHIBITOR REMARK 900 RELATED ID: 3N0N RELATED DB: PDB REMARK 900 THE SAME PROTEIN WITH A SIMILAR INHIBITOR REMARK 900 RELATED ID: 3MZC RELATED DB: PDB REMARK 900 THE SAME PROTEIN WITH A SIMILAR INHIBITOR REMARK 900 RELATED ID: 3N4B RELATED DB: PDB REMARK 900 THE SAME PROTEIN WITH A SIMILAR INHIBITOR DBREF 3N3J A 1 261 UNP P00918 CAH2_HUMAN 1 260 SEQRES 1 A 260 MET SER HIS HIS TRP GLY TYR GLY LYS HIS ASN GLY PRO SEQRES 2 A 260 GLU HIS TRP HIS LYS ASP PHE PRO ILE ALA LYS GLY GLU SEQRES 3 A 260 ARG GLN SER PRO VAL ASP ILE ASP THR HIS THR ALA LYS SEQRES 4 A 260 TYR ASP PRO SER LEU LYS PRO LEU SER VAL SER TYR ASP SEQRES 5 A 260 GLN ALA THR SER LEU ARG ILE LEU ASN ASN GLY HIS ALA SEQRES 6 A 260 PHE ASN VAL GLU PHE ASP ASP SER GLN ASP LYS ALA VAL SEQRES 7 A 260 LEU LYS GLY GLY PRO LEU ASP GLY THR TYR ARG LEU ILE SEQRES 8 A 260 GLN PHE HIS PHE HIS TRP GLY SER LEU ASP GLY GLN GLY SEQRES 9 A 260 SER GLU HIS THR VAL ASP LYS LYS LYS TYR ALA ALA GLU SEQRES 10 A 260 LEU HIS LEU VAL HIS TRP ASN THR LYS TYR GLY ASP PHE SEQRES 11 A 260 GLY LYS ALA VAL GLN GLN PRO ASP GLY LEU ALA VAL LEU SEQRES 12 A 260 GLY ILE PHE LEU LYS VAL GLY SER ALA LYS PRO GLY LEU SEQRES 13 A 260 GLN LYS VAL VAL ASP VAL LEU ASP SER ILE LYS THR LYS SEQRES 14 A 260 GLY LYS SER ALA ASP PHE THR ASN PHE ASP PRO ARG GLY SEQRES 15 A 260 LEU LEU PRO GLU SER LEU ASP TYR TRP THR TYR PRO GLY SEQRES 16 A 260 SER LEU THR THR PRO PRO LEU LEU GLU CYS VAL THR TRP SEQRES 17 A 260 ILE VAL LEU LYS GLU PRO ILE SER VAL SER SER GLU GLN SEQRES 18 A 260 VAL LEU LYS PHE ARG LYS LEU ASN PHE ASN GLY GLU GLY SEQRES 19 A 260 GLU PRO GLU GLU LEU MET VAL ASP ASN TRP ARG PRO ALA SEQRES 20 A 260 GLN PRO LEU LYS ASN ARG GLN ILE LYS ALA SER PHE LYS HET ZN A 262 1 HET GOL A 303 14 HET WWV A 263 41 HETNAM ZN ZINC ION HETNAM GOL GLYCEROL HETNAM WWV 4-({[2-(1-METHYLETHYL)PHENYL]CARBAMOYL}AMINO) HETNAM 2 WWV BENZENESULFONAMIDE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 ZN ZN 2+ FORMUL 3 GOL C3 H8 O3 FORMUL 4 WWV C16 H19 N3 O3 S FORMUL 5 HOH *359(H2 O) HELIX 1 1 HIS A 15 ASP A 19 5 5 HELIX 2 2 PHE A 20 GLY A 25 5 6 HELIX 3 3 LYS A 127 GLY A 129 5 3 HELIX 4 4 ASP A 130 VAL A 135 1 6 HELIX 5 5 LYS A 154 GLY A 156 5 3 HELIX 6 6 LEU A 157 ASP A 162 1 6 HELIX 7 7 VAL A 163 LYS A 168 5 6 HELIX 8 8 ASP A 180 LEU A 185 5 6 HELIX 9 9 SER A 219 ARG A 227 1 9 SHEET 1 A 2 ASP A 32 ILE A 33 0 SHEET 2 A 2 THR A 108 VAL A 109 1 O THR A 108 N ILE A 33 SHEET 1 B10 LYS A 39 TYR A 40 0 SHEET 2 B10 LYS A 257 ALA A 258 1 O ALA A 258 N LYS A 39 SHEET 3 B10 TYR A 191 GLY A 196 -1 N THR A 193 O LYS A 257 SHEET 4 B10 VAL A 207 LEU A 212 -1 O VAL A 207 N GLY A 196 SHEET 5 B10 LEU A 141 VAL A 150 1 N GLY A 145 O ILE A 210 SHEET 6 B10 ALA A 116 ASN A 124 -1 N LEU A 118 O ILE A 146 SHEET 7 B10 THR A 87 TRP A 97 -1 N GLN A 92 O VAL A 121 SHEET 8 B10 PHE A 66 PHE A 70 -1 N VAL A 68 O PHE A 93 SHEET 9 B10 SER A 56 ASN A 61 -1 N LEU A 57 O GLU A 69 SHEET 10 B10 SER A 173 ASP A 175 -1 O ALA A 174 N ILE A 59 SHEET 1 C 6 LEU A 47 SER A 50 0 SHEET 2 C 6 VAL A 78 GLY A 81 -1 O VAL A 78 N SER A 50 SHEET 3 C 6 THR A 87 TRP A 97 -1 O TYR A 88 N LEU A 79 SHEET 4 C 6 ALA A 116 ASN A 124 -1 O VAL A 121 N GLN A 92 SHEET 5 C 6 LEU A 141 VAL A 150 -1 O ILE A 146 N LEU A 118 SHEET 6 C 6 ILE A 216 VAL A 218 1 O ILE A 216 N PHE A 147 LINK ZN ZN A 262 N1 WWV A 263 1555 1555 1.90 LINK NE2 HIS A 96 ZN ZN A 262 1555 1555 2.00 LINK NE2 HIS A 94 ZN ZN A 262 1555 1555 2.01 LINK ND1 HIS A 119 ZN ZN A 262 1555 1555 2.07 CISPEP 1 SER A 29 PRO A 30 0 -1.65 CISPEP 2 PRO A 201 PRO A 202 0 8.69 SITE 1 AC1 4 HIS A 94 HIS A 96 HIS A 119 WWV A 263 SITE 1 AC2 10 ASN A 62 HIS A 64 ALA A 65 ASN A 67 SITE 2 AC2 10 GLN A 92 HIS A 94 WWV A 263 HOH A 421 SITE 3 AC2 10 HOH A 435 HOH A 550 SITE 1 AC3 12 HIS A 94 HIS A 96 HIS A 119 PHE A 131 SITE 2 AC3 12 LEU A 198 THR A 199 THR A 200 TRP A 209 SITE 3 AC3 12 ZN A 262 GOL A 303 HOH A 362 HOH A 392 CRYST1 42.293 41.433 71.820 90.00 104.18 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023645 0.000000 0.005975 0.00000 SCALE2 0.000000 0.024135 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014361 0.00000 MASTER 293 0 3 9 18 0 7 6 0 0 0 20 END